Science
Pfizer To Buy Weight-Loss Drug Developer Metsera
By CNBC
Pfizer on Monday said it would buy weight loss drugmaker Metsera in an up to $7.3 billion deal, including future payments, as it scrambles to win a slice in the booming obesity drug market.
Pfizer said it will pay an initial $47.50 a share in cash fo ...Read more
